-
Forward Look
From Cold Virus to Cancer FighterNeurosurgeon Frederick F. Lang discusses virus-powered cancer treatments.
by Sue Rochman
-
Forward Look
Opening Clinical Trials to HIV-Positive Cancer PatientsIncluding patients with HIV is part of a larger effort to broaden cancer clinical trial eligibility.
by Andy Kopsa
-
Forward Look
Lung Cancer Biology Differs by Race, Study ShowsResearch findings could help improve personalized treatments for lung cancer patients.
by Stephen Ornes
-
Pushing the Immune System to Its LimitsImmunotherapy drugs have led to long-lasting remissions for some cancer patients with advanced disease. They also come with a new and diverse array of side effects.
by Kate Yandell
-
What Older Patients ValueMany older adults with cancer place more importance on maintaining their independence and cognitive abilities than on living as long as possible.
by Cheryl Platzman Weinstock
-
Omitting ObesityMany cancer clinical trials do not track what proportion of enrolled patients are obese, a study finds. These patients may be underrepresented in research.
by Cici Zhang
-
Measuring Your MovementResearchers are exploring whether wearable personal activity monitors could provide doctors with a more complete picture of cancer patients' well-being.
by Brad Jones
-
Men Less Likely to Get Genetic TestingA study suggests women are more likely than men to undergo genetic testing for mutations linked to hereditary cancer.
by Cheryl Platzman Weinstock
-
The Ins and Outs of Tumor TestingIn a session at the AACR Annual Meeting, oncologists discussed the state of cancer precision medicine—and engaged with patient advocates.
by Kate Yandell
-
A Response to RoadblocksThe Biden Cancer Initiative Colloquium gathered experts to discuss obstacles preventing access to care at the AACR Annual Meeting.
by Kevin McLaughlin
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona
-
Ultraproccessed Foods and Cancer RiskThe idea that ultraprocessed foods are associated with increased risk of metabolic and cardiovascular diseases is well supported, but what does the evidence reveal about these foods and cancer?
-
What Are the Benefits of Exercise for Cancer Patients?Several recent studies have explored how exercise can impact a cancer patient’s survival, risk of recurrence, and overall quality of life.
Cancer Research at a Crossroads
